Why the study?
The study aimed to investigate the associations of LDL-C, non-HDL-C, TG, and HDL-C with metabolic dysfunction-associated fatty liver disease (MAFLD), specifically focusing on effect modification by BMI and the unique role of TG.
Population
7035 hospital-based high-risk participants who underwent FibroTouch examinations
Comparison
Serum lipid parameters (LDL-C, non-HDL-C, TG, HDL-C) across BMI categories (non-overweight vs overweight/obese)
Design
Cross-sectional study
Answers are grounded in this paper and cite their sources.
TG-BMI synergy in MAFLD association is hypothesis-generating; cross-sectional data leave open causal inference and clinical adoption.
Aim To investigate the associations of low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) with metabolic dysfunction-associated fatty liver disease (MAFLD), with a specific focus on the effect modification by body mass index (BMI) and the unique role of TG. Methods This cross-sectional study included 7035 participants who underwent FibroTouch examinations. Multivariable logistic regression, restricted cubic splines, subgroup analyses, additive interaction analyses, and ROC curves were used to assess the associations between lipid parameters and MAFLD. Results Elevated LDL-C, non-HDL-C, and TG were positively associated with MAFLD, while HDL-C was negatively associated (all p < 0.001). All lipid-MAFLD associations were significantly modified by BMI (all P for interaction < 0.001), with stronger associations in non-overweight individuals. Only TG showed a significant synergistic effect with high BMI (RERI = 12.99, 95% CI: 7.59–19.84) and had the highest AUC (AUC = 0.759). However, no lipid parameters were independently associated with significant liver fibrosis. Conclusion In this hospital-based population undergoing metabolic-liver assessment, the associations between lipid parameters and MAFLD were universally modified by BMI, with stronger associations observed in non-overweight individuals. TG may play a unique dual role: it appeared to be the strongest correlate of MAFLD among lipid parameters in non-overweight individuals, showed a synergistic effect with BMI in overweight/obese individuals, and had the highest AUC among single lipid parameters for MAFLD. In clinical practice, hypertriglyceridemia in non-overweight individuals may warrant attention, and the combined effect of high TG and high BMI in overweight/obese individuals could be recognized.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: